(Q41912805)

English

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

scientific article published on January 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

author name string

Schmitt M

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Thomssen C

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Ulm K

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Seiderer A

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Harbeck N

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Höfler H

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Jänicke F

7

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Graeff H

8

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

76

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

306-311

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.383

0 references

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Ligand binding regulates the directed movement of beta1 integrins on fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Regulation of integrin function by the urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Novel methods for the determination of the angiogenic activity of human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

5 June 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2224071

18 August 2018

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing importance of prognostic factors in breast cancer during long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time dependency of the influence of prognostic factors on relapse in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9252196

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.383

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41912805&oldid=2169423766"